IQV - IQV IQVIAホ―ルディングス （）

IQVIA Holdings found using ticker (IQV) have now 19 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 300 and 235 calculating the average target price we see 267.16. Now with the previous closing price of 182.89 this now indicates there is a potential upside of 46.1%. The 50 day MA is 221.32 while the 200 day moving average is 228.18. The market capitalisation for the company is $34,633m. You can visit the company''s website by visiting: https://www.iqvia.com [stock_market_widget type="chart" template="basic" color="green" assets="IQV" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $50,590m based on the market concensus. IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

Mumbai (Maharashtra)/Bangalore (Karnataka) [India], September 28 (ANI/BusinessWire India): IQVIA (NYSE: IQV) today announced that Dr. Reddy''s Laboratories (Dr Reddy''s), a leading multinational pharmaceutical company based in India, has selected IQVIA Orchestrated Customer Engagement (OCE) platform as its core CRM solution for its entire field force in India.

Mumbai, Maharashtra, Bangalore, Karnataka, India: IQVIA (NYSE: IQV) as we speak introduced that Dr. Reddy’s Laboratories (Dr. Reddy’s), a number one multinational pharmaceutical firm based […] The post IQVIA Announces Partnership with Dr. Reddy’s Laboratories for CRM Solution for India Field Force appeared first on Businessfortnight .

IQVIA Holdings with ticker code (IQV) now have 19 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 300 and 235 with a mean TP of 267.16. With the stocks previous close at 212.51 this would indicate that there is a potential upside of 25.7%. The 50 day moving average now sits at 225.76 and the 200 day MA is 231.99. The company has a market capitalisation of $39,004m. Company Website: https://www.iqvia.com [stock_market_widget type="chart" template="basic" color="green" assets="IQV" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $49,035m based on the market concensus. IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

IQVIA Holdings with ticker code (IQV) have now 19 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 300 and 235 with the average target price sitting at 268.21. Given that the stocks previous close was at 209.66 this now indicates there is a potential upside of 27.9%. There is a 50 day moving average of 225.28 and the 200 day MA is 233.16. The market capitalisation for the company is $40,125m. Visit the company website at: https://www.iqvia.com [stock_market_widget type="chart" template="basic" color="green" assets="IQV" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $51,331m based on the market concensus. IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

IQVIA Holdings found using ticker (IQV) have now 18 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 290 and 235 with a mean TP of 264. With the stocks previous close at 219.68 this is indicating there is a potential upside of 20.2%. The day 50 moving average is 212.3 and the 200 day moving average is 236.18. The market capitalisation for the company is $41,989m. You can visit the company''s website by visiting: https://www.iqvia.com [stock_market_widget type="chart" template="basic" color="green" assets="IQV" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $50,460m based on the market concensus. IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

IQVIA Holdings Inc. (NYSE:IQV) concluded the trading at $221.74 on Friday, July 22 with a fall of -1.72% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $225.63 and 5Y monthly beta was reading 1.46 with its price kept floating in the … New Insight On IQVIA Holdings Inc. (IQV) Read More »

The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, IQVIA Holdings is now the #22 analyst pick, moving up by 1 spot.

IQVIA Holdings Inc. (NYSE: IQV) Q2 2022 earnings call dated Jul. 21, 2022

https://www.investing.com/news/pro/iqvia-holdings-pt-raised-to-261-at-jefferies-432SI-2851905

IQVIA Holdings found using ticker (IQV) have now 17 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 300 and 231 and has a mean target at 279.12. With the stocks previous close at 238.36 this is indicating there is a potential upside of 17.1%. There is a 50 day moving average of 231.83 and the 200 moving average now moves to 249.3. The market capitalisation for the company is $45,877m. Find out more information at: https://www.iqvia.com [stock_market_widget type="chart" template="basic" color="green" assets="IQV" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $53,722m based on the market concensus. IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

IQVIA Holdings with ticker code (IQV) have now 17 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 300 and 231 with the average target price sitting at 279.12. Now with the previous closing price of 233.59 this would imply there is a potential upside of 19.5%. The 50 day moving average now sits at 232.39 and the 200 day MA is 249.53. The company has a market capitalisation of $44,162m. Find out more information at: https://www.iqvia.com [stock_market_widget type="chart" template="basic" color="green" assets="IQV" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $52,770m based on the market concensus. IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

Related Stocks: CVNA , ROAD , RIVN , EXPE , TXRH , PCG , IQV ,

IQVIA Holdings with ticker code (IQV) have now 17 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 325 and 255 with the average target price sitting at 289.94. Given that the stocks previous close was at 228.64 this is indicating there is a potential upside of 26.8%. The day 50 moving average is 257.76 and the 200 moving average now moves to 251.16. The company has a market capitalisation of $44,356m. Company Website: https://www.iqvia.com [stock_market_widget type="chart" symbol="IQV" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] The potential market cap would be $56,248m based on the market concensus. IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.